Predictions
Epam Systems Inc.
Start price
Target price
Perf. (%)
€355.60
01.11.22
01.11.22
€300.00
01.11.23
01.11.23
-41.45%
28.06.23
28.06.23
High Investments for future growth
Very valuable balance sheet
Leading role in innovation
Very positive Cash Flow expected
Pharmaron Beijing Co. Ltd.
Start price
Target price
Perf. (%)
€3.80
01.11.22
01.11.22
-
01.11.23
01.11.23
40.79%
15.11.22
15.11.22
Could be worthwhile Investment >10% per year
Longfor Group Holdings Limited
Start price
Target price
Perf. (%)
€1.35
01.11.22
01.11.22
-
01.11.23
01.11.23
88.15%
15.11.22
15.11.22
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€758.30
01.11.22
01.11.22
€900.00
01.11.23
01.11.23
-9.34%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€42.60
01.11.22
01.11.22
€55.00
31.12.24
31.12.24
-10.33%
04.11.22
04.11.22
Could be very worthwhile Investment >20% year
Sanofi S.A.
Start price
Target price
Perf. (%)
€88.01
01.11.22
01.11.22
€100.00
31.12.24
31.12.24
13.11%
05.05.23
05.05.23
Could be worthwhile Investment >10% per year
Marathon Oil Corp.
Start price
Target price
Perf. (%)
€30.83
31.10.22
31.10.22
€45.00
31.12.23
31.12.23
-34.16%
05.05.23
05.05.23
Could be worthwhile Investment >10% per year
Uber Technologies Inc
Start price
Target price
Perf. (%)
€27.51
31.10.22
31.10.22
€36.00
31.12.23
31.12.23
10.53%
01.11.22
01.11.22
Could be very worthwhile Investment >20% year
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€61.10
31.10.22
31.10.22
€48.00
31.12.24
31.12.24
0.98%
21.12.22
21.12.22
Could be worthwhile Investment >10% per year
AMTD IDEA Group ADR
Start price
Target price
Perf. (%)
€2.10
31.10.22
31.10.22
-
31.10.23
31.10.23
-3.81%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Very capable Management
Few uniques
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€1.57
31.10.22
31.10.22
-
31.10.23
31.10.23
74.57%
01.11.22
01.11.22
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.47
31.10.22
31.10.22
€18.00
31.12.24
31.12.24
19.77%
31.10.22
31.10.22
Could be very worthwhile Investment >20% year
Bigbear.ai Holdings Inc.
Start price
Target price
Perf. (%)
€1.35
31.10.22
31.10.22
-
31.10.23
31.10.23
62.96%
24.04.23
24.04.23
Business model of the past or high risk
Risky Investment
StoneCo Ltd
Start price
Target price
Perf. (%)
€10.31
30.10.22
30.10.22
€13.00
30.10.23
30.10.23
-11.85%
31.10.23
31.10.23
Could be worthwhile Investment >10% per year
TCR2 Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.56
30.10.22
30.10.22
-
30.10.23
30.10.23
-16.12%
12.11.22
12.11.22
Risky Investment
AMTD IDEA Group ADR
Start price
Target price
Perf. (%)
€2.10
30.10.22
30.10.22
-
30.10.23
30.10.23
-3.81%
12.11.22
12.11.22
Could be very worthwhile Investment >20% year
Dingdong (cayman) Ltd.
Start price
Target price
Perf. (%)
€2.54
30.10.22
30.10.22
-
30.10.23
30.10.23
38.58%
24.04.23
24.04.23
Probably not worthwhile Investment
GDS Holdings Ltd ADR
Start price
Target price
Perf. (%)
€8.40
30.10.22
30.10.22
-
30.10.23
30.10.23
61.90%
24.04.23
24.04.23
Probably not worthwhile Investment
China Mengniu Dairy Co Ltd
Start price
Target price
Perf. (%)
€3.15
30.10.22
30.10.22
-
30.10.23
30.10.23
11.64%
24.04.23
24.04.23
Probably not worthwhile Investment
Oracle Corp.
Start price
Target price
Perf. (%)
€77.60
30.10.22
30.10.22
€80.00
30.10.23
30.10.23
2.81%
04.01.23
04.01.23
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€362.80
29.10.22
29.10.22
€400.00
29.10.23
29.10.23
6.95%
05.05.23
05.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
McDonalds Corp.
Start price
Target price
Perf. (%)
€273.00
29.10.22
29.10.22
€255.00
29.10.23
29.10.23
0.37%
22.05.23
22.05.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group